AZRX News and Press, AzurRx BioPharma Inc. From 04/15/20

BROOKLYN, NY / ACCESSWIRE / April 15, 2020 / AzurRx BioPharma, Inc. (NASDAQ:AZRX), is a clinical stage biopharmaceutical company focused on the development of recombinant proteins for the treatment of gastrointestinal diseases, today announced that it will be presenting at the Planet MicroCa...

NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”) a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases today announced the appointment of Gre...

Received ~$1.8 million in aggregate CIR payments in 2020 CIR offers support for on-going MS1819 Phase 2 clinical studies in Europe NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company s...

NEW YORK, NY / ACCESSWIRE / March 18, 2020 / AzurRx BioPharma (NASDAQ:AZRX) will be presenting at this year's Spring Investor Summit on March 25 th -26 th . During the current climate of concern, The Spring Investor Summit will now take place virtually, featuring over 500 registered executi...

Presentation to focus on Phase II Trial of MS1819 in Cystic Fibrosis (CF) Discussion of safety and efficacy endpoints of bridging dose safety study NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”...

Gainers: Cemtrex (NASDAQ: CETX )  +100% . More news on: Cemtrex, Inc., OrganiGram Holdings Inc., Fluent, Inc., Stocks on the move, , Read more ...

Accelerate Diagnostics (NASDAQ: AXDX )  -13%  on soft guidance . More news on: Accelerate Diagnostics, Inc., Nektar Therapeutics, Inpixon, Stocks on the move, , Read more ...

The following slide deck was published by AzurRx BioPharma, Inc. in conjunction with this Read more ...

Gainers: RTI Surgical RTIX  +66% . More news on: IRIDEX Corporation, Inpixon, Gritstone Oncology, Inc., Stocks on the move, , Read more ...

Stemline Therapeutics (NASDAQ: STML )  -22%  on preliminary Q4 revenue. More news on: Stemline Therapeutics, Inc., Avinger, Inc., DURECT Corporation, Stocks on the move, Read more ...